Indiscriminate use of corticosteroid-containing eyedrops

Mayo Clinic Proceedings

Volumn 74, Issue 4, 1999, Pages 362-366

  Baratz, Keith H ^a   Hattenhauer, Matthew G ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DEXAMETHASONE; DEXAMETHASONE PLUS TOBRAMYCIN; DEXAMETHASONE SODIUM PHOSPHATE; GENTAMICIN; LATANOPROST; MAXITROL; PRED G; PREDNISOLONE; SULFACETAMIDE; TIMOLOL; TIMOLOL MALEATE; TOBRAMYCIN; UNCLASSIFIED DRUG; VASOCIDIN;

ADOLESCENT; ADULT; ARTICLE; ATOPY; BLEPHARITIS; CASE REPORT; DIFFERENTIAL DIAGNOSIS; EYE DISEASE; FEMALE; GLAUCOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATITIS; MALE; SLIT LAMP; STEROID THERAPY; TONOMETRY; VIRAL CONJUNCTIVITIS;

EID: 0032963009     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/74.4.362     Document Type: Article

References (35)

1. Kulkami PS. Steroidal and nonsteroidal drugs in endotoxin-induced uveitis. J Ocul Pharmacol 1994;10:329-334
2. Sainz de la Maza M, Jabbur NS, Foster CS. An analysis of therapeutic decision for scleritis. Ophthalmology 1993;100:1372-1376
3. Campos M, Abed HM, McDonnell PJ. Topical fluorometholone reduces stromal inflammation after photorefractive keratectomy. Ophthalmic Surg 1993:24:654-657
4. Coles RS. Steroid therapy in uveitis. Int Ophthalmol Clin 1966 Winter;6:869-901
5. Rinne JR, Stulting RD. Current practices in the prevention and treatment of corneal graft rejection. Cornea 1992;ll:326-328
6. Wilson SE, Kaufman HE. Graft failure after penetrating keratoplasty. Surv Ophthalmol 1990:34:325-356
7. Leske MC, Chylack LT Jr, Wu SY. The Lens Opacities Case-Control Study: risk factors for cataract. Arch Ophthalmol 1991;109:244-251
8. Stern JJ. Acute glaucoma during cortisone therapy. Am J Ophthalmol 1953:36:389-390
9. Black RL, Oglesby RB, von Sallmann L, Bunlm JJ. Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis. JAMA 1960:174:166-171
10. Goldmann H. Cortisone glaucoma. Arch Ophthalmol 1962:68:621-626
11. Frandsen E. Glaucoma and cataract as complications to topical steroid therapy. Acta Ophthalmol (Copenh) 1966;44:307-312
12. Cubey RB. Glaucoma following the application of corticosteroid to the skin of the eyelids. Br J Dermatol 1976;95:207-208
13. Dreyer EB. Inhaled steroid use and glaucoma [letter]. N Engl J Med 1993;329:1822
14. Gumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997;337:8-14
15. Vajpayee RB, Gupta SK, Bareja U, Kishore K. Ocular atopy and mycotic keratitis. Ann Ophthalmol 1990;22:369-372
16. Ormerod LD. Causes and management of bacterial keratitis in the elderly. Can J Ophthalmol 1989;24:112-116
17. Smolln G, Okumoto M, Leong-Sit L Combined gentamicin-tobramycincorticosteroid treatment. II. Effect on gentamicin-resistant Pseudomonas keratitis. Arch Ophthalmol 1980;98:473-474
18. Romanowski EG, Roba LA, Wiley L, Araullo-Cruz T, Gordon YJ. The effects of corticosteroids on adenoviral replication. Arch Ophthalmol 1996:114:581-585
19. Kaufman HE, Rayfield MA, Gebhardt BM. Herpes simplex viral infections. In: Kaufman HE, Barron BA, McDonald MB, editors. The Cornea. 2nd ed. Boston: Butterworth-Heinemann; 1998. pp 247277
20. Flcker L, Ramakrishnan M, Seal D, Wright P. Role of cell-mediated immunity to staphylococci in blepharitis. Am J Ophthalmol 1991:111:473-479
21. Mondlno BJ. Inflammatory diseases of the peripheral cornea. Ophthalmology 1988:95:463-472
22. Frucht-Pery J, Sag! E, Memo I, Ever-Hadani P. Efficacy of doxycycline and tetracycline in ocular rosacea. Am J Ophthalmol 1993;116:8892
23. O'Day DM, Ray WA, Head WS, Robinson RD, Williams TE. Influence of corticosteroid on experimentally induced keratomycosis. Arch Ophthalmol 1991:109:1601-1604
24. LiesegangTJ. Contact lens-related microbial keratitis. Parti. Epidemiology. Cornea 1997;16:125-131
25. Rao GN. Complications due to daily wear soft contact lenses. In: Dabezies OH Jr, editor. Contact Lenses: The CLAO Guide to Basic Science and Clinical Practice. Orlando (FL): Grune & Stratton; 1986. pp 42.1-42.7.0
26. Erie JC, Nevitt MP, Hodge DO, Ballard DJ. Incidence of ulcerative keratitis in a defined population from 1950 through 1988. Arch Ophthalmol 1993;111:1665-1671
27. Neumann M, SJostrand J. Central microbial keratitis in a Swedish city population: a three-year prospective study in Gothenburg. Acta Ophthalmol 1993;71:160-164
28. Palmer ML, Hyndiuk RA. Contact lens-related infectious keratitis. Int Ophthalmol Clin 1993 Winter;33:23-49
29. Bacon AS, Dart JKG, Ficker LA, Matheson MM, Wrlght P. Acanthamoeba keratitis: the value of early diagnosis. Ophthalmology 1993:100:1238-1243
30. Kaufman HE. Use of corticosteroids in corneal disease and external diseases of the eye. Int Ophthalmol Clin 1966 Winter;6:827843
31. Stern GA, Buttress M. Use of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal disease. Ophthalmology 1991:98:847-853
32. Armaly MF. Statistical attributes of the steroid hypertensive response in the clinically normal eye. I. The demonstration of three levels of response. Invest Ophthalmol 1965:4:187-197
33. Armaly MF. Effect of corticosteroids on intraocular pressure and fluid dynamics. II. The effect of dexamethasone in the glaucomatous eye. Arch Ophthalmol 1963:70:492-499
34. Becker B, Hahn KA. Topical corticosteroids and heredity in primary open-angle glaucoma. Am J Ophthalmol 1964:57:543-551
35. Covell LL. Glaucoma induced by systemic steroid therapy. Am J Ophthalmol 1958:45:108-109